Ashwagandha (Withania somnifera) is an ancient botanical from the nightshade (Solanaceae) family that has seen an extraordinary surge of commercial popularity in the UK. However, the promotional marketing surrounding this herbal extract often runs far ahead of what clinical trials actually demonstrate.
This editorial overview evaluates published clinical trials on Ashwagandha, detailing the differences between traditional use and modern research, botanical extract standardisation, potential physiological interactions, and important safety considerations for men over 40.
Key Takeaway
While small-scale human trials suggest that standardised Ashwagandha root extracts may support perceived stress reduction and sleep parameters, botanicals are not pharmacological substitutes for medical treatment and must be approached with informed caution.
1. Traditional Herbalism vs Modern Clinical Trials
Ashwagandha has a centuries-long history in traditional Ayurvedic medicine, where whole root powders were historically consumed with milk or honey. In modern clinical research, however, investigators typically administer proprietary, highly concentrated aqueous or alcoholic extracts standardised for specific withanolide glycoside content.
Because commercial products vary widely in plant part (root versus leaf), extraction solvent, and withanolide concentration, study findings obtained with one specific formulation cannot be automatically extrapolated to all retail supplements.
2. What the Clinical Evidence Actually Shows
In recent years, several randomised, double-blind, placebo-controlled trials (RCTs) have investigated standardised Ashwagandha extracts in adult cohorts:
- Perceived Stress & Cortisol: Multiple 8-to-12 week RCTs have noted statistically significant reductions in self-reported perceived stress scores and moderate declines in serum morning cortisol concentrations compared to placebo.
- Sleep Quality: Studies examining adults experiencing non-restorative sleep observed modest improvements in sleep onset latency and overall sleep efficiency.
- Physical Performance & Recovery: Pilot studies in resistance-trained men noted small increases in muscle strength and perceived recovery, though long-term clinical significance remains under active investigation.
| Research Domain | Observed Outcome in Trials | Scientific Limitations |
|---|---|---|
| Perceived Stress | Statistically significant decrease in PSS scores and cortisol. | Short study durations (mostly 8–12 weeks); subjective self-reporting. |
| Sleep Quality | Modest reduction in sleep latency and nighttime awakenings. | Small sample sizes; varied extract standardisation across trials. |
| Hormonal Parameters | Small fluctuations in DHEA-S and free testosterone in stressed cohorts. | Results not replicated across all age groups; clinical relevance debated. |
3. Safety, Contraindications, and Regulatory Status in the UK
In Great Britain, Ashwagandha supplements are regulated as food supplements under the Food Standards Agency (FSA). They are not licensed medicines by the MHRA and are not approved to treat anxiety disorders, clinical depression, or endocrine hypogonadism.
Important Contraindications
Ashwagandha is not suitable for everyone. It may interact with prescription medications or aggravate underlying medical conditions:
- Thyroid Disorders: May elevate thyroid hormone synthesis, interacting with levothyroxine.
- Autoimmune Conditions: Immune-stimulating properties may trigger flares in conditions such as rheumatoid arthritis or lupus.
- Sedatives & Anxiolytics: Potential additive sedative effects when combined with benzodiazepines or sleep medications.
- Liver Health: Rare cases of idiosyncratic liver injury have been reported in international pharmacovigilance databases; individuals with liver impairment should avoid use.
4. How to Inspect a Supplement Label Carefully
If you and your GP decide that a botanical supplement is appropriate for your circumstances:
- Verify that the product clearly specifies the plant part (100% root extract is preferred over leaf blends).
- Look for standardised withanolide percentages (typically between 2.5% and 5%).
- Avoid proprietary multi-herb blends that conceal exact botanical dosages.
- Limit use to cyclical periods (e.g., 6–12 weeks) rather than indefinite continuous consumption.
Scientific References & Authoritative Sources
- Stress & Cortisol Clinical Trial: Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med, 2012; 34(3):255-265.
- Sleep Quality Study: Langade D, et al. Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study. Evid Based Complement Alternat Med, 2021.
- UK Food Standards Agency (FSA): Guidance on Food Supplements and Botanical Ingredients. food.gov.uk, updated 2024.
- European Medicines Agency (EMA): Public statement on Withania somnifera (L.) Dunal, radix. Committee on Herbal Medicinal Products (HMPC), 2023.